Cantab Pharmaceuticals
- Date:
- 1997-1998
- Reference:
- SA/KET/A/3/2
- Part of:
- The Kennedy Trust for Rheumatology Research
- Archives and manuscripts
About this work
Description
Item contains draft licensing agreements, letters of intent and correspondence relating to a research collaboration between the Kennedy Institute and Cantab Pharmaceuticals. The collaboration largely focused on the licensing and exploitation of patent application led by Kennedy Institute Scientist Dr Yuti Chernajovsky. Item also includes collaboration agreement including Marc Feldmann for the study of OX40 in mouse collagen induced arthritis model of rheumatoid arthritis.
Publication/Creation
1997-1998
Physical description
1 file (in 2 parts)
Terms of use
This item is held in offsite storage and requires a longer time for delivery.
Where to find it
Location Status Access Closed stores